10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2019 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 24, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Revenues | $ 26,145 | 22,561 | 20,776 |
| Cost of Goods and Services Sold | 8,078 | 6,467 | 6,014 [1] |
| Marketing, selling and administrative | 4,871 | 4,551 | 4,751 |
| Research and development | 6,148 | 6,332 | 6,468 |
| Amortization of Acquired Intangible Assets | 1,135 | 97 | 97 |
| Other income (net) | 938 | (854) | (1,685) |
| Total Expenses | 21,170 | 16,593 | 15,645 |
| Earnings Before Income Taxes | 4,975 | 5,968 | 5,131 |
| Provision for Income Taxes | 1,515 | 1,021 | 4,156 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | 3,460 | 4,947 | 975 |
| Net Income (Loss) Attributable to Noncontrolling Interest | 21 | 27 | (32) |
| Net Earnings Attributable to BMS | 3,439 | 4,920 | 1,007 |
| Earnings per Common Share | |||
| Basic Earnings Per Common Share Attributable to BMS | 2.02 | 3.01 | 0.61 |
| Diluted Earnings per Common Share Attributable to BMS | 2.01 | 3.01 | 0.61 |
| Principal Transaction Revenue, Description of Reporting Category | |||
| Net product sales | |||
| Revenues | 25,174 | 21,581 | 19,258 |
| Alliance and other revenues | |||
| Revenues | 971 | 980 | 1,518 |
| [1] Excludes amortization of acquired intangible assets. | |||
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2019 | |||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 24, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 3,460 | 4,947 | 975 |
| Other Comprehensive Income (Loss), net of taxes and reclassifications to earnings [Abstract] | |||
| Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax | (32) | 70 | (57) |
| Pension and postretirement benefits | 1,203 | 53 | 214 |
| Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax | 36 | (25) | 39 |
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | 35 | (254) | 18 |
| Other Comprehensive Income (Loss), Net of Tax | 1,242 | (156) | 214 |
| Comprehensive Income | 4,702 | 4,791 | 1,189 |
| Comprehensive Income Attributable to Noncontrolling Interest | 21 | 27 | (32) |
| Comprehensive Income Attributable to BMS | 4,681 | 4,764 | 1,221 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2019 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 24, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Cash Flows From Operating Activities: | |||
| Net Earnings | $ 3,460 | 4,947 | 975 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Depreciation and amortization, net | 1,746 | 637 | 789 |
| Deferred income taxes | (924) | 45 | 453 |
| Stock-based compensation | 441 | 221 | 199 |
| Impairment charges | 199 | 126 | 327 |
| Pension settlements and amortization | 1,688 | 186 | 236 |
| Divestiture gains and royalties | (1,855) | (992) | (706) |
| Asset acquisition charges | 25 | 85 | 760 |
| Loss/(gain) on equity investments | (279) | 512 | (23) |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | 523 | 0 | 0 |
| Other adjustments | (22) | (44) | 120 |
| Changes in operating assets and liabilities: | |||
| Receivables | 752 | (429) | (431) |
| Inventories | 463 | (216) | (29) |
| Accounts payable | 229 | (59) | 320 |
| Deferred income | 12 | 84 | (642) |
| Income taxes payable | 907 | 203 | 3,154 |
| Other | 702 | 634 | (227) |
| Net Cash Provided by Operating Activities | 8,067 | 5,940 | 5,275 |
| Cash Flows From Investing Activities: | |||
| Sale and maturities of marketable securities | 3,809 | 2,379 | 6,398 |
| Purchase of marketable securities | (3,961) | (2,305) | (5,419) |
| Capital expenditures | (836) | (951) | (1,055) |
| Divestiture and other proceeds | 15,852 | 1,249 | 736 |
| Acquisition and other payments | (24,634) | (1,246) | (726) |
| Net Cash Provided by/(Used in) Investing Activities | (9,770) | (874) | (66) |
| Cash Flows From Financing Activities: | |||
| Short-term borrowings, net | 131 | (543) | 727 |
| Issuance of long-term debt | 26,778 | 0 | 1,488 |
| Repayment of long-term debt | (9,256) | (5) | (1,224) |
| Repurchase of common stock | (7,300) | (320) | (2,469) |
| Dividends | (2,679) | (2,613) | (2,577) |
| Other | (53) | (54) | (22) |
| Net Cash Used in Financing Activities | 7,621 | (3,535) | (4,077) |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | (9) | (41) | 52 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | 5,909 | 1,490 | 1,184 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 12,820 | 6,911 | 5,421 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2019 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2019 10-K (Filed: Feb 24, 2020) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2019 | Dec 31, 2018 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 12,346 | 6,911 |
| Marketable securities, current | 3,047 | 1,848 |
| Receivables | 7,685 | 5,747 |
| Inventories | 4,293 | 1,195 |
| Other current assets | 1,983 | 2,015 |
| Total Current Assets | 29,354 | 17,716 |
| Property, plant and equipment | 6,252 | 5,027 |
| Goodwill | 22,488 | 6,538 |
| Other intangible assets | 63,969 | 1,091 |
| Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | 510 | 815 |
| Marketable securities, noncurrent | 767 | 1,775 |
| Other Assets, Noncurrent | 6,604 | 2,024 |
| Total Assets | 129,944 | 34,986 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term debt obligations | 3,346 | 1,703 |
| Accounts payable | 2,445 | 1,892 |
| Other current liabilities | 12,513 | 7,059 |
| Total Current Liabilities | 18,304 | 10,654 |
| Deferred Income Tax Liabilities, Net | 6,454 | 19 |
| Long-term debt, excluding current maturities | 43,387 | 5,646 |
| Other Liabilities, Noncurrent | 10,101 | 4,540 |
| Total Liabilities | 78,246 | 20,859 |
| Commitments and contingencies | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 3,568 in 2019 and 3,590 in 2018, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.9 billion issued in 2019 and 2.2 billion issued in 2018 | 292 | 221 |
| Capital in excess of par value of stock | 43,709 | 2,081 |
| Accumulated other comprehensive loss | (1,520) | (2,762) |
| Retained earnings | 34,474 | 34,065 |
| Less cost of treasury stock - 672 million common shares in 2019 and 576 million common shares in 2018 | (25,357) | (19,574) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 51,598 | 14,031 |
| Noncontrolling interest | 100 | 96 |
| Total Equity | 51,698 | 14,127 |
| Total Liabilities and Equity | 129,944 | 34,986 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |